Compare IMNM & SYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMNM | SYBT |
|---|---|---|
| Founded | 2006 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.4B |
| IPO Year | 2020 | 2009 |
| Metric | IMNM | SYBT |
|---|---|---|
| Price | $19.53 | $75.08 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 6 |
| Target Price | $35.20 | ★ $90.20 |
| AVG Volume (30 Days) | ★ 1.3M | 135.9K |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 1.74% |
| EPS Growth | ★ 51.40 | 22.11 |
| EPS | N/A | ★ 2.55 |
| Revenue | $6,941,000.00 | ★ $23,406,000.00 |
| Revenue This Year | N/A | $15.13 |
| Revenue Next Year | $18,747.97 | $8.33 |
| P/E Ratio | ★ N/A | $29.76 |
| Revenue Growth | N/A | ★ 3.37 |
| 52 Week Low | $13.53 | $61.51 |
| 52 Week High | $30.06 | $89.22 |
| Indicator | IMNM | SYBT |
|---|---|---|
| Relative Strength Index (RSI) | 30.12 | 34.54 |
| Support Level | $19.39 | $74.73 |
| Resistance Level | $23.48 | $82.14 |
| Average True Range (ATR) | 1.12 | 1.55 |
| MACD | -0.27 | -0.20 |
| Stochastic Oscillator | 13.81 | 8.32 |
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
Stock Yards Bancorp Inc operates as a bank holding company providing commercial banking and wealth management services. Its Commercial Banking segment offers loan and deposit products to consumers and businesses, including retail and mortgage lending, deposit services, online and mobile banking, private banking, commercial and real estate lending, treasury and merchant services, international and correspondent banking, credit cards, and brokerage services through a third-party broker-dealer. Its Wealth Management and Trust (WM&T) segment provides investment management, financial and retirement planning, trust and estate services, and retirement plan management, with WM&T revenue distinguishing the company from similarly sized community banks.